Researchers at UTHealth Houston are transforming skin cells into miniature brains to study schizophrenia and other mental ...

A new study examining real-world hospital data reveals early indicators of who is most likely to benefit from Cobenfy, the ...

New research published in the American Journal of Psychiatry provides new molecular insights into the role of the habenula, a ...

A pioneering therapy targeting distressing and disturbing mental images for people with psychosis could lead to a ...

A new imagery-focused therapy called iMAPS may help people with psychosis gain control over disturbing mental images that ...

An international panel of leading women’s mental health experts – including UVA Health’s Jennifer Payne, MD – is calling to reclassify postpartum psychosis as its own category of mental illness to ...

A recent study suggests that individuals with psychotic disorders process sensations they produce themselves, such as their ...

Cobenfy, the first new schizophrenia drug in 50 years, offers early insights that could pave the way for more personalized ...

A pioneering therapy targeting distressing and disturbing mental images for people with psychosis could lead to a ...

A common antibiotic may help lower the risk of some young people developing schizophrenia, a new study suggests.